 |
 |
|
 |
 |
 |
IQuum Receives SBIR-NIH Phase II Grant for Development of Lab-in-a-Tube Blood Testing System Allston, MA, August 15, 2002 -- IQuum, Inc. has been awarded a $1.4 million Small Business Innovation Research (SBIR) Phase II grant from the National Heart, Lung and Blood Institute (NHLBI) for the development of the Liat™ diagnostic blood testing system. The system is aimed at meeting the growing demand for practical near-patient testing. Based on the Company's lab-in-a-tube technology, the Liat blood testing system will use novel sample handling, microfluidic, and imaging technologies to achieve system miniaturization, low cost, high flexibility, and improved safety. In this Phase II research, the company will continue the development of the lab-in-a-tube platform initiated in the Phase I efforts and develop platelet function and coagulation assays as the first applications for the Liat blood testing system.About IQuum, Inc. IQuum is a leader in developing lab-in-a-tube technology, a novel biological sample testing platform intended to provide revolutionary benefits to a broad cross section of the bioassay market. The Company's proprietary technology will enable the less experienced professional to perform more sophisticated biological sample testing in a less expensive setting with greater speed. The lab-in-a-tube platform is the foundation of next generation tools for clinical diagnostics, biodefense, and industrial testing. Founded in 1998, IQuum is located in the Boston metropolitan area in Massachusetts. For more information, please visit www.IQuum.com.
|